KFDA pushes separation of manufacturing license from product license

The Korea Food and Drug Administration said in the 2004 main affairs that it has drafted a revision bill designed to separate the manufacturing license from product license in a bid to help support the industrialization of Korea's biotechnology sector.

The administration said the revision draft will be finalized possibly during the first half of this year and the separation will cover all ph...